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Following intravenous (i.v.) and intraportal (i.ptl.) injection of cells tumour colonies localised in lung and liver respectively due to tumour cell arrest. Arterially injected radiolabelled cells disseminated and arrested in a similar distribution to cardiac output and did not 'home' to any organs. Following arterial injection of unlabelled tumour cells colonies grew in many organs. While the pattern of growth for a particular tumour varied with the cell dose, the 'arterial patterns' for all of the tumours studied followed a similar pattern. Some organs (eg adrenals, ovaries and periodontal ligament) were consistently preferred, others (eg skin and skeletal muscle) only supported tumour growth following the delivery of large numbers of cells, while in some tissues (eg spleen and intestines) tumour never grew.
Viable tumour cells could be demonstrated by bioassay in many organs for up to 24h after i.a. injection. However tumour growth only occurred in certain organs and the pattern of this growth was not related to the number of tumour cells arrested or their rate of autolysis. This site preference could be expressed quantitatively as the probability of an arrested cell developing into a tumour and was considered a 'soil effect'. Site preference was not directly related to organ vascularity. Organ colonisation was promoted by steroid treatment but the mechanism was unclear and was not secondary to T-cell In explaining the mechanism of site selectivity by bloodborne metastasis the haemodynamic theory of Ewing (1928) stressed the importance of the mechanics of the circulation whereas the Soil/Seed hypothesis of Paget (1889) emphasized the importance of the environment in which the trapped emboli found themselves. The eventual sites of metastasis are, however, determined by both haemodynamic and soil/seed factors. Haemodynamic factors are important following the venous discharge of tumour cells since the 'organs of first encounter' are the commonest site for bloodborne metastasis -the lung after systemic venous discharge of tumour cells and the liver after portal venous discharge (Viadana et al., 1978) . The present study emphasizes that the 'soil' becomes important when tumour cells have entered the systemic arterial circulation and are thereby delivered to all organs. Clinically this situation can occur when cells are released from primary or secondary lung tumours or possibly when cells released into the venous circulation manage to traverse the lung capillaries.
In this paper we extend earlier data (Murphy et al., 1986 ) on the pattern of spread of rat syngeneic non-lymphoid and non-haemopoietic tumours following intravenous (i.v.), intraportal (i.ptl.) and intra-arterial (i.a.) injection. In our i.v. and i.ptl. studies as well as previously reported studies tumour growth is essentially limited to the 'organs of first encounter' and the study of mechanisms of site selectivity is therefore limited. In order to deliver tumour cells to all organs we have injected them intra-arterially via the intracardiac (i.c.) route. Labelled cell distribution after i.c. injection has been compared with the distribution of cardiac output (measured using the microsphere technique) in order to establish whether cells disseminate and arrest passively or whether they recirculate and localise in certain organs. The 'arterial pattern' of tumour growth after unlabelled cell injection has then been compared with the arterial distribution of labelled tumour cells to establish and quantitate the 'soil effect'.
Having established a 'soil effect' after arterial injection of tumour cells we have attempted to determine the mechanisms using several approaches. Firstly a correlation of site selectivity with organ vascularity (using data obtained from the microsphere studies) was sought since there have been reports that more vascular organs might be more susceptible to metastasis (Weiss et al., 1981) . Secondly the rate of autolysis of trapped labelled cells in different organs has been compared with the organs susceptibility to tumour growth. Thirdly we have intervened pharmacologically to see if site preference can be altered and finally we have rendered refractory organs susceptible to tumour growth by trauma.
The pharmacological studies took two directions. Because steroids promoted sarcoma and hepatoma tumour growth in liver and kidney possible steroid dependence of the sarcoma was looked for by testing if adrenalectomy inhibited tumour growth. To establish if the steroid potentiating effect was related to T-cell immunosuppression or inhibition of prostaglandin synthesis the animals were treated with cyclosporin A or a non-steroidal anti-inflammatory agent flurbiprofen.
As the adrenal gland in our studies was found to be a universally preferred site of tumour colonisation the possibility that locally high steroid concentrations in the adrenal provided an environment conducive to tumour growth as examined by testing if the steroid inhibitors metyrapone and aminoglutethimide inhibited tumour growth in the adrenal. We did not test the role of catecholamines in adrenal preference by interfering with it's tissue levels but instead studied the effect of blocking the beta action of catecholamines with propranolol.
We found that sites of trauma or healing were especially susceptible to tumour growth. The possibility that this was related to increased bloodflow and hence increased delivery of tumour cells was eliminated using the microsphere method. The possibility that it was related to the macrophage response of the inflammatory process was then studied in an intraperitoneal (i.p.) system. The omentum was found to be very susceptible to tumour growth after i.p. injection of tumour cells. This organ is very rich in monocytes and macrophages (Liebermann-Meffert & White, 1983) and following local administration of the branched chain hydrocarbon pristane there is a dramatic enlargement of the omentum (Leak et al., 1985) and production of a exudate rich in macrophages which, however, are not cytocidal (Alexander, 1976 I.a. injections were made through cannulae (Portex 800/100/100) inserted retrogradely via the right carotid artery into the left ventricle of the ether anaesthetized rat. In early studies the animals were allowed to wake and were then injected. In later studies, when cannulation was performed more rapidly, tumour cells were injected into anaesthetised rats at the time of cannulation and this became the preferred method of injection.
Tumours
Six chemically induced syngeneic to the hooded Lister rat were used in the intravascular experiments (Table I) (Ishise et al., 1980 (Tables II and III) . However, after i.a. injection tumour colonies form in many organs (Tables IV-VII) . This demonstrates that the failure to cause systemic tumour growth following i.v. and i.ptl. inoculation is not because the cells cannot grow in distant organs but is due to the inability of significant numbers of cells to pass in a viable state through the capillaries of the lung and liver.
Following the i.v. and i.ptl. injection of radiolabelled tumour cells, radioactivity was essentially confined to the lung and liver respectively (Tables VIII-X). The small amount of radioactivity that was in other organs shortly after i.v. injection comes from labelled debris and dying cells contained in the inoculate. This was demonstrated by the i.v. HRGCll sarcoma 6/6 0/6
(1 x 106) aAt times when animals became unwell from lung lesions (see Materials and methods). Cultured and directly disaggregated cell preparations included. ( ) Indicates the frequency with which the adrenals and ovaries developed unilateral metastasis as opposed to both organs being involved; aSingle metastases in each core; bThese develop microscopic metastases; 'Not all animals were examined for metastases at these sites; dConscious rats; eAnaesthetized rats; 'Only rats developing metastases included.
injections of deliberately damaged cell preparations which led to high fractions of radioactivity localising to the liver while after the injection of a cell preparation cleared of debris the radioactivity in the liver was low (Table XI) . The debris is presumably cleared by the reticuloendothelial system. Hepatoma cell preparations contained a greater proportion of non-viable cells which probably explains the higher fraction in the liver after i.v. injection (Table IX) . With time radioactivity accumulates in other organs (Table  VIII) Tables XII and XIII) with the eventual pattern of tumour growth (see Tables IV and VI) shows no correlation ie tumour colonisation is site selective. The overall pattern of tumour growth for all the tumours studied (Tables IV-VII) show that they have similar site preferences. Organs such as the adrenals, ovaries, periodontal ligament and bone were consistently preferred sites of colonisation, others such as the pancreas, diaphragm, skin and skeletal muscle only developed tumour colonies (rarely more than 10 in skin or muscle) following the delivery of large numbers (106) (Table XVIII) and also in 5 out of 7 rats given 106 hepatoma cells i.a. In the kidneys microscopic glomerular tumour deposits were routinely observed after i.a. injection of 106 sarcoma MC28 cells. Although viable cells could be demonstrated on bioassay these growths did not develop into macroscopic lesions. However if dexamethasone was given at the time of tumour injection or as long as two days afterwards large overt tumour growths developed (Table XVIII) .
Attempts were made to ascertain why steroid treatment potentiated the growth of tumour colonies. Sarcoma MC28 tumour cells injected into animals bilaterally adrenalectomised on day -8, or day +7, or at the same time as the cancer cells were injected to see if the tumour was steroid dependent but there was no inhibition of the growth of tumour in any of the susceptible organs of these rats (data not shown). To see if tumour potentiation by the steroids was mediated by T-cell immunosuppression or by the inhibition of prostaglandin synthesis the sarcoma cells were injected into six rats treated with cyclosporin A given s.c. at 25 mg kg-1 four times weekly commencing one day before tumour inoculation or flurbiprofen (given 7 mg kg-1 twice daily also commencing on day -1 -see Heckford et al., 1982) respectively. Neither of these treatments caused the develop- Modification of adrenal metabolism Attempts were made to influence tumour colonisation in the adrenals by blocking steroid production using aminoglutethimide in a 3-day schedule giving 250, 125, 62 mg kg-1 on days -1 through to Table XII ). Although the percentage of cardiac output going to muscle wounds was higher in the healing muscle -0.77+0.17% as compared to 0.35+0.19% in the same weight of adjacent non-traumatised muscle (n=5 rats), this cannot account for the very marked localisation of tumour in the wounds. When quantified (as already done above for different organs) the probability of an arrested sarcoma cell in the wound developing into a colony is -1 in 130 whereas in non-traumatised skeletal muscle it is -1,000 times less likely.
Deliberate manipulation of the liver, partial hepatectomy or treatment with carbon tetrachloride before or around the time of arteriall inoculation of sarcoma MC28 promoted liver tumour colony formation (Table XX) . Manipulation at the time of i.ptl. injection of sarcoma MC28 similarly potentiated the incidence of development of tumour growths (Table XX) .
Promotion of tumour growth in the peritoneal cavity by pristane Since trauma potentiated bloodborne tumour colonisation and since this could not be explained by an increased delivery of cells alternative mechanisms were examined. The timing of the promotional effect of trauma in the case for muscle coincides with the time when macrophages infiltrate the wound and the importance of these was tested using an i.p. system. The peritoneal cavity is a favoured site for the Carcass, skin, pancreas, bladder, thymus and thyroid all excluded for technical reasons.
The rest of the organs were totalled and called 100% at each time point. will grow when transplanted into the peritoneal cavity. Intraperitoneal tumour growth of the inoculated sarcomas and hepatoma was initially confined to the omentum as discrete nodules, before spread by direct extension to the mesentery, testicular or fallopian fat, the diaphragm, organ capsules and muscle wall. Pristane treatment of the rat's peritoneum produced a macrophage rich ascites which was maximal between 12 and 18 days later when the number of mononuclear cells from a peritoneal wash rose from 7.5 x 106 to 19 x 107. By 40 days the number of peritoneal leukocytes had returned to normal but the omentum was still enlarged and highly cellular. By 100 days the omentum had a normal appearance and MC28 sarcoma grew as in control rats.
Pre-treatment with pristance prior to i.p. injection of cells greatly facilitated tumour growth as measured by a reduction in TD50, but was most dramatic in terms of tumour mass (Table XXI) . Although this was difflcult to quantify in the pristane treated groups as the tumour spread rapidly, by killing pristane treated rats at 7 and 9 days after tumour inoculation it could be seen that these tumours had their origin in the greater omentum. 
Discussion
Our studies and those of others (eg Greene & Harvey 1964; Fidler, 1970; Proctor, 1976 ; Van de Velde et al., 1977; Becker, 1978; Tarin & Price, 1979; Nanni et al., 1983; Wilmott et al., 1983; Barnet & Eccles, 1984) show that the lungs are with few exceptions the preferred site for bloodborne colonies from 'non-lymphoid' and 'nonhaemopoietic' tumours injected into the systemic veins. Although the method in these studies whereby tumour cells are injected into vasculature is very artificial, the lung is also the commonest site for 'spontaneous' metastases derived from tumours implanted such that they develop systemic venous drainage (eg Ketcham et al., 1961; Price et al., 1982; Nanni et al., 1983; Barnett & Eccles, 1984; Alterman et al., 1985; Wingen & Schmahl, 1985) . Following i.ptl. injection of tumour cells, the liver is likewise the preferred site of tumour growth -in both our studies and others (Fisher & Fisher, 1965; Vaage, 1973; Proctor, 1976; Tarin & Price, 1981; Dingemans & Roos, 1982) .
The observation that colonisation of extrapulmonary and extrahepatic sites after i.v. or i.ptl. injection did not occur despite the ability of many organs to support tumour growth following the arterial delivery of low numbers of cells confirmed that the lung and liver capillary beds were trapping delivered tumour cells. This general pattern is also true for many other tumours injected via all three vascular routes, eg B16 melanoma (i.v. -Fidler, 1970; i.p. -Dingemans & Roos, 1982;  i.a. -Weiss et al., 1984) , mouse mammary tumours (i.v. -Tarin & Price, 1979; i.p. -Tarin & Price, 1981; i.a. -Jaucaba et al., 1983) , mouse KHT sarcoma (i.v. -Siemann & Mulcahy, 1984; i.a. -Conley, 1979) , mouse sarcoma (i.v., i.p. & i.a. -Vaage, 1973) , rat allogeneic Walker carcinoma (i.v. -Agostino & Clifton, 1965; i.p. -Fisher & Fisher, 1965;  i.a. -Sugarbaker, 1952) , rat sarcoma, (i.v., i.p. & i.a. -Proctor, 1976) .
Lymphoid or haemopoietic derived tumours behave differently and demonstrate the ability to traverse capillary beds since after i.v. injection they grow preferentially in sites distal to the lung such as the liver, spleen and bone (Potter et al., 1957; Kobayashi et al., 1962; Greene & Harvey, 1964; Pilgrim, 1969; Pilgrim, 1971; Parks, 1974; Sadler & Alexander, 1976; Hart et al., 1981; Willmott et al., 1983; Konings et al., 1985) and when labelled the radioactivity accumulates in the liver, spleen and intestines rather than the lungs (Hoelzer et al., 1973; Sinha & Goldberg, 1974; loachim et al., 1976; Sadler & Alexander, 1976) . The cells of only a few 'solid' tumours demonstrate the ability to traverse the lung capillaries (some described by Greene & Harvey, 1963; Kinsey & Smith, 1959; Zeidman & Buss, 1952; Alessandri et al., 1981) and also 'especially selected' variant cell lines derived from B 16 murine melanoma (Fidler & Nicolson, 1976; Brunson et al., 1978; Tao et al. 1979; Brunson & Nicolson, 1979; Raz & Hart, 1980; Fidler, 1984) .
The mechanics of the circulation (Ewing's hypothesis) therefore determine the localisation of bloodborne colonies from 'solid tumours' in lung and liver after venous injection of cells and also determines the comparable localisation of metastases in the clinical situation (Murphy et al., 1986 (Murphy et al., ,1987 . However, from our studies it is apparent that once tumour cells enter the arterial circulation it is 'soil' factors that determine the pattern of tumour growth (Paget's hypothesis) . Weiss et al. (1984) observed similar results using the B16 melanoma in the mouse.
We have shown that arterially injected tumour cells distribute and arrest in parallel with the distribution of cardiac output. The results of our cardiac output studies are similar to those that have been published previously (eg Foster & Frydman, 1977; Tsuchiya et al., 1978; Ishise et al., 1980) . However, the eventual pattern of tumour growth does not bear any relation to the pattern of tumour cell arrest or rate of autolysis. The likelihood of tumour cells surviving in different organs to become tumour growths (or 'soil effect') has been quantified in our studies and varies by a factor of several thousand between susceptible and refractory organs.
Various factors to explain site selectivity by bloodborne tumour have been postulated and include adhesion between tumour cells and their target organs (Netland & Zetter, 1984) , biochemical factors (Nicolson & Dulski, 1986; Horak et al., 1986) , slow blood flow and attenuated endothelial linings (eg Tavassoli & Shaklai, 1979) , the possession of different cell surfaces (Irimura & Nicolson, 1984) , immunological factors (Hanna & Fidler, 1981) , and the production in host tissues of growth factors needed for isolated cancer cells to grow (postulated by Alexander et al., 1985) .
Much of the work of Fidler (1984) and co-workers has emphasized the heterogenous nature of tumours and consequently the possibility that pre-existing variants in a tumour may have the potential to metastasize to specific sites. In contrast our studies and the results of the three other studies in the rat in which tumour cells have been injected (Suemasu et al., 1970; Sugarbaker, 1952; Proctor, 1976) show a broad similarity of arterial pattern of tumour colonisation. In man the 'arterial pattern' of carcinoma metastasis is also similar whatever the carcinoma type, whether it is primary lung tumour or lung metastasis discharging cells into the arterial circulation (Murphy et al., 1987 ). Thus we have studied factors affecting organ environments rather than cell variants with specific site selectivities.
Our initial approach to the study of site selectivity was pharmacological. We observed that dexamethasone promoted sarcoma MC28 tumour colonisation in the liver and kidneys (organs which did not normally develop overt growth of tumour colonies) and hepatoma colonisation in the liver. The mechanisms of this effect remain unclear. If this promotion were secondary to the immunosuppressive effects of steroids, then it is not mediated by immunological factors relating to T-cell action since cyclosporin A did not have this promotional effect. Furthermore it does not seem to be mediated by the prostaglandin synthesis inhibiting action of steroids (Samuelsson et al., 1979) since the nonsteroidal anti-inflammatory flurbiprofen (also inhibiting prostaglandin synthesis -Heckford et al., 1982) did not alter the arterial colonisation pattern. Hydrocortisone is known to facilitate the growth in vitro of freshly explanted cancer cells from human cancers and is routinely added to media used to clone human tumours. While it is tempting to attribute tumour colony promotion by dexamethasone in the kidney and liver to a mitogenic activity of corticosteroids, the failure of dexamethasone to induce tumour colonies at other sites such as intestines renders this hypothesis improbable.
Our second approach was to study the mechanisms underlying tumour growth in the adrenals. Preferential adrenal gland metastasis is not only a feature in the rat but is also observed in man (Murphy et al., 1987) , in the rabbit (Coman et al., 1951; Knisely & Mahaley, 1958; Alexander & Altemeier, 1964) , and in the mouse (Vaage, 1973; Conley, 1979; Jaucaba et al., 1983; Weiss et al., 1984) . In the instances of extrapulmonary tumour growth occurring in mice after i.v. injection of tumour cells, adrenal or ovarian involvement is again fairly common (Fidler & Nicolson, 1976; Brunson et al., 1978; Raz & Hart, 1980; Willmott et al., 1983; Siemann & Mulcahy, 1984; Barnett & Eccles, 1984; Stackpole et al., 1985; Alterman et al., 1985) . Our autoradiographic studies showed that the sarcoma MC28 tumour cells arrested in the periphery of the adrenal cortex -probably where the branching arterial subcapsular plexus breaks up into cortical capillaries (Coupland, 1974) . Tumour growth was also usually in this region and this prompted the question as to whether the locally high concentration of steroids might be promoting tumour formation (especially since steroids potentiated growth in the liver and kidneys). Attempts to block steroid production in the adrenals with aminoglutethimide and metypyrone did not inhibit or delay the development of adrenal tumour colonies or colonies at other sites. However these drugs do not block steroid production completely (Temple & Liddle, 1970) and no definite conclusion is therefore possible. Adrenalectomy was also not found to delay the development of metastases at other sites suggesting that factors other than steroid concentration were more important in metastasis growth. We have not attempted to test the role of catecholamines by interfering with tissue levels but rather by blocking beta action with propranolol. However this did not alter the pattern or incidence of colony formation.
Trauma has been observed to facilitate the growth of bloodborne tumour and this confirms earlier studies of Robinson and Hoppe (1962) , Alexander and Altemeier (1964) and Agostino and Clifton (1965) . Although we have shown an increased delivery of blood (and hence tumour cells) to damaged and healing muscle in our experiments this is insufficient to explain the marked susceptibility of this muscle to bloodborne tumour growth. Tissue healing of all kinds can be broadly divided into 3 phases -an initial inflammatory (exudative) phase, a proliferative phase and a reorganisation or remodelling phase (Leibovich & Ross, 1975; Forrest, 1983) . There is initial platelet activation and coagulation and then loss of fluid into the extravascular spaces. Neutrophils also extravasate and reach a peak level after 2 days and then decrease. Macrophages peak at about 3 days, persist for longer, and are important in both phagocytosis and stimulating tissue repair (Leibovich & Ross, 1975) . This is then followed by a process of neovascularisation and repair or regeneration.
The timing of trauma potentiation of tumour colonisation in the muscle wounds coincided with the arrival of the macrophages and the possibility was considered that these, while promoting healing, might also promote tumour growth. Pristane introduced into the peritoneum will induce a general inflammatory reaction but it is characterised largely by a macrophage response. Pretreatment with pristane prior to i.p. tumour cell injection potentiated tumour growth. Macrophages might therefore be implicated in promoting tumour growth in these circumstances but the point is not proven. If this potentiation were secondary to the increased numbers of macrophages then it might be because of the many types of polypeptide growth factors they produce -including PDGF and EGF (Leslie et al., 1984; Hamburger & White, 1986; Nordan & Potter, 1986; Morne et al., 1986; Rich, 1986) .
For trauma potentiation of liver tumour growth to occur tumour cell inoculation and trauma have to be timed much more closely, ie before the macrophage response has time to develop. This would indicate that promotion of growth of tumour emboli in the liver by trauma is unlikely to be caused by macrophages. Nor do we have any reason for attributing preference for tumour colonisation in normal non-traumatised organs such as adrenal or ovary to macrophages.
